Guardant Health (GH) Cash & Current Investments (2017 - 2026)

Guardant Health (GH) has 10 years of Cash & Current Investments data on file, last reported at $1.1 billion in Q1 2026.

• Quarterly Cash & Current Investments rose 57.86% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 57.86% YoY) and the FY2025 annual result came in at $1.2 billion, up 43.05% from the prior year.
• Cash & Current Investments slipped to $1.1 billion in Q1 2026 per GH's latest filing, from $1.2 billion in the prior quarter.
• The five-year high for Cash & Current Investments was $1.2 billion in Q2 2023, with the low at $580.0 million in Q3 2025.
• Average Cash & Current Investments over 5 years is $951.8 million, with a median of $958.0 million recorded in 2022.
• Year-over-year, Cash & Current Investments slumped 52.35% in 2022 and jumped 57.86% in 2026.
• Guardant Health's Cash & Current Investments stood at $1.0 billion in 2022, then climbed by 15.57% to $1.2 billion in 2023, then dropped by 28.12% to $840.0 million in 2024, then jumped by 43.05% to $1.2 billion in 2025, then fell by 8.23% to $1.1 billion in 2026.
• Business Quant data shows GH's Cash & Current Investments at $1.1 billion in Q1 2026, $1.2 billion in Q4 2025, and $580.0 million in Q3 2025.